Condition or disease | Intervention/treatment |
---|---|
Length of Stay | Other: Portsmouth Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (P-POSSUM) score |
Study Type : | Observational |
Actual Enrollment : | 225 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Correlation Between P-POSSUM Score and Length of Stay in Kidney Transplant Recipients |
Actual Study Start Date : | May 15, 2018 |
Actual Primary Completion Date : | August 15, 2018 |
Actual Study Completion Date : | October 18, 2018 |
Group/Cohort | Intervention/treatment |
---|---|
Not prolonged length of stay
Living donor patients who had ≤ 6 days length of stay after laparoscopic nephrectomy procedure
|
Other: Portsmouth Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (P-POSSUM) score
P-POSSUM score's variables are divided into physiological parameters (age, cardiac, respiratory, ECG, systolic blood pressure, pulse rate, haemoglobin, leukocyte count, urea, sodium plasma, potassium plasma, and GCS) and operative parameters (operation type, number of procedures, operative blood loss, peritoneal contamination, malignancy status, CEPOD).
|
Prolonged length of stay
Living donor patients who had > 6 days length of stay after laparoscopic nephrectomy procedure
|
Other: Portsmouth Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (P-POSSUM) score
P-POSSUM score's variables are divided into physiological parameters (age, cardiac, respiratory, ECG, systolic blood pressure, pulse rate, haemoglobin, leukocyte count, urea, sodium plasma, potassium plasma, and GCS) and operative parameters (operation type, number of procedures, operative blood loss, peritoneal contamination, malignancy status, CEPOD).
|
The score for Age variable cut-off:
4 point >71 years
The score for heart disease variable cut-off:
4 point for peripheral edema, warfarin, or borderline cardiomegaly on chest X-ray (CXR)
The score for lung disease variable cut-off:
4 points for limiting dyspnea or moderate COPD on CXR 8 points for dyspnea at rest or fibrosis/consolidation on CXR
The score for ECG abnormality variable cut-off:
1 point for normal ECG 4 points for atrial fibrillation (HR 60-90 8 points for 5 ectopic beats/min, Q waves or ST/T wave change
The score for systolic blood pressure variable cut-off:
4 points for > 170 mmHg or 90-99 mmHg 8 points for < 90 mmHg
The score for pulse rate variable cut-off:
4 points for 101-120 bpm 8 points for > 121 bpm or < 40 bpm
The score for hemoglobin variable cut-off:
4 points for 10-11.4 or 17.1-18 g/dL 8 points for <10 or >18 g/dL
The score for leukocyte count variable cut-off:
4 points for >20.000 atau <3.000/mm3
The score for plasma potassium concentration variable cut-off:
4 points for 2.9-3.1 or 5.4-5.9 mmol/L 8 points for <2.9 or >5.9 mmol/L
The score for plasma sodium concentration variable cut-off:
4 points for 126-130 mmol/L 8 points for <126 mmol/L
The score for number of procedures variable cut-off:
1 point for one 4 points for two 8 points for more than two
The score for intraoperative blood loss variable cut-off:
4 points for 501-999 mL 8 points for > 999 mL
The score for peritoneal contamination/soiling variable cut-off:
4 points for local pus 8 points for free bowel content, pus or blood
The score for presence of malignancy variable cut-off:
4 points for nodal metastases 8 points for distant metastases
The score for mode of surgery variable cut-off:
1 point for elective 4 points for emergency resuscitation of > 2 hours possible operation < 24 hours after admission 8 points for emergency (immediate surgery < 2 hours needed)
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Indonesia | |
Rumah Sakit Cipto Mangunkusumo | |
Jakarta Pusat, DKI Jakarta, Indonesia, 10430 |
Study Chair: | Dita Aditianingsih, M.D, PhD | Department of Anesteshiology and Intensive Care, Cipto Mangunkusumo Hospital, Universitas Indonesia |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | April 24, 2019 | ||||
First Posted Date | May 1, 2019 | ||||
Last Update Posted Date | May 1, 2019 | ||||
Actual Study Start Date | May 15, 2018 | ||||
Actual Primary Completion Date | August 15, 2018 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | No Changes Posted | ||||
Current Secondary Outcome Measures |
|
||||
Original Secondary Outcome Measures | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | P-POSSUM Score and Length of Stay | ||||
Official Title | Correlation Between P-POSSUM Score and Length of Stay in Kidney Transplant Recipients | ||||
Brief Summary | P-POSSUM score had a predictive power of >80% to predict the length of stay of kidney transplant recipients | ||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Cohort Time Perspective: Retrospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Medical record of recipients who undewernt kidney transplant during a period between January 2015 and December 2017 | ||||
Condition | Length of Stay | ||||
Intervention | Other: Portsmouth Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (P-POSSUM) score
P-POSSUM score's variables are divided into physiological parameters (age, cardiac, respiratory, ECG, systolic blood pressure, pulse rate, haemoglobin, leukocyte count, urea, sodium plasma, potassium plasma, and GCS) and operative parameters (operation type, number of procedures, operative blood loss, peritoneal contamination, malignancy status, CEPOD).
|
||||
Study Groups/Cohorts |
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Completed | ||||
Actual Enrollment |
225 | ||||
Original Actual Enrollment | Same as current | ||||
Actual Study Completion Date | October 18, 2018 | ||||
Actual Primary Completion Date | August 15, 2018 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | 18 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers | No | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | Indonesia | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT03933137 | ||||
Other Study ID Numbers | IndonesiaUAnes034 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement | Not Provided | ||||
Responsible Party | Dita Aditianingsih, Indonesia University | ||||
Study Sponsor | Indonesia University | ||||
Collaborators | Not Provided | ||||
Investigators |
|
||||
PRS Account | Indonesia University | ||||
Verification Date | April 2019 |